HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Idiotype and anti-idiotype specific T cell responses on transplantation with hybridomas reactive to viral hemagglutinin and human tumor antigen.

Abstract
B cell hybridomas expressing class I and II MHC molecules and producing antibodies directed against hemagglutinin protein of Rinderpest virus and human Mucin-1 have been used as surrogate B cells to study T cell responses against the antigens. The observed CTL and lymphoproliferative response indicates that anti-idiotypic B cells termed Jerne cells stimulate both T helper and T cytotoxic cells by virtue of their ability to present recycled or regurgitated peptido-mimics of antigen to T helper cells through class II MHC and de novo synthesized peptido-mimics of antigens to CTLs. Thus, T cell memory response can be perpetuated by anti-idiotypic Jerne B cells and these findings lend support to the earlier proposed relay hypothesis for perpetuation of immunological memory (IM).
AuthorsShibani Mitra-Kaushik, M S Shaila, Anjali Karande, Rabindranath Nayak
JournalImmunology letters (Immunol Lett) Vol. 80 Issue 2 Pg. 81-7 (Feb 01 2002) ISSN: 0165-2478 [Print] Netherlands
PMID11750038 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Antigens, Neoplasm
  • Epitopes
  • Hemagglutinins, Viral
Topics
  • Animals
  • Antibodies (immunology)
  • Antigens, Neoplasm (immunology)
  • B-Lymphocytes (immunology)
  • Cell Transplantation
  • Epitopes (immunology)
  • Hemagglutinins, Viral (immunology)
  • Humans
  • Hybridomas (immunology, transplantation)
  • Mice
  • T-Lymphocytes, Cytotoxic (immunology)
  • T-Lymphocytes, Helper-Inducer (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: